Tick-borne encephalitis virus
Tick-borne encephalitis virus (TBEV) is a virus responsible for tick-borne encephalitis (TBE), a disease affecting the central nervous system. TBEV is a member of the Flaviviridae family and is transmitted to humans through the bite of infected ticks. The virus can cause a wide range of symptoms, from mild flu-like symptoms to severe neurological damage, and in some cases, it can be fatal.
Transmission and Distribution[edit]
TBEV is primarily transmitted to humans through the bite of infected Ixodes ticks, particularly Ixodes ricinus and Ixodes persulcatus. These ticks are found in forested areas of Europe and northern Asia, from eastern France to northern Japan and from northern Russia to Albania. The virus can also be transmitted through the consumption of unpasteurized milk from infected animals.
Clinical Manifestation[edit]
The disease manifests in two phases. The first phase occurs about a week after the tick bite and presents as a nonspecific flu-like illness, with symptoms such as fever, headache, fatigue, and muscle pain. After a symptom-free period of about a week, approximately a third of infected individuals enter the second phase, which involves the central nervous system, leading to meningitis, encephalitis, or meningoencephalitis. The severity of the disease can vary significantly, from mild cases with full recovery to severe cases resulting in paralysis, permanent neurological damage, or death.
Prevention and Treatment[edit]
Prevention of TBEV infection is primarily through avoiding tick bites by wearing protective clothing, using insect repellents, and performing regular tick checks after visiting tick-infested areas. Vaccination is available and recommended for people living in or traveling to areas where TBE is common. There is no specific antiviral treatment for TBE; management of the disease focuses on supportive care to relieve symptoms.
Epidemiology[edit]
The incidence of TBE is increasing in many parts of Europe and Asia, attributed to various factors including climate change, which affects tick distribution and activity, and increased human activity in areas where infected ticks are found. Public health measures and vaccination programs are crucial in preventing TBE in endemic areas.
Sponsored Health Resource

W8MD Weight Loss, Sleep & MedSpa
Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.
GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.
- Medical weight loss NYC
- Affordable GLP-1 injections NYC
- Budget GLP-1 weight loss shots Philadelphia
- New Jersey medical weight loss
- NYC medical weight loss blog
- Philadelphia weight loss blog
- Sleep medicine and sleep apnea services
- W8MD MedSpa and wellness
Book a W8MD appointment · View GLP-1 specials
Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian